EIP
CC icon

Ellis Investment Partners’s Chemours CC Stock Holding History

Ellis Investment Partners’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-34
Closed – – 725
2020
Q2 		$0 Hold
34
– – ﹤0.01% 711
2020
Q1 		$0 Sell
34
-6
-15% -$87 ﹤0.01% 721
2019
Q4 		$0 Sell
40
-59
-60% -$980 ﹤0.01% 676
2019
Q3 		$1K Buy
99
+60
+154% +$976 ﹤0.01% 675
2019
Q2 		$0 Buy
+39
New +$1.15K ﹤0.01% 652

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Ellis Investment Partners's CC Position: Q3 2020 in Review

Ellis Investment Partners sold out of Chemours (CC) in Q3 2020, closing a stake of 34 shares.

Ellis Investment Partners first reported a position in CC in Q2 2019 and held it in 5 quarters. The position peaked at $1K in Q3 2019. 384 funds tracked by Wall St. Rank hold CC as of Q3 2020.

  • Ellis Investment Partners reported no remaining Chemours position as of Q3 2020 after selling out during the quarter.
  • Ellis Investment Partners sold 34 Chemours shares in Q3 2020.
  • Ellis Investment Partners first reported a position in Chemours in Q2 2019 and held it in 5 quarters.
  • Ellis Investment Partners's Chemours position peaked at $1K in Q3 2019.
  • 384 funds tracked by Wall St. Rank held Chemours as of Q3 2020.

Based on Ellis Investment Partners's 13F filing for Q3 2020, filed 19 Oct 2020.